Viking Global Investors — TRVI Trade History
Quarter-by-quarter changes in the TREVI THERAPEUTICS INC position · CUSIP 89532M101
Currently held · 4 YearsFirst seen: 2022 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 1,544,644 | -1,654,000 | -51.7% | $28.8M | 0.08% |
| 2026 Q1 | 2026-05-15 | Hold | 3,198,644 | — | 0.0% | $38.2M | 0.11% |
| 2025 Q4 | 2026-02-17 | Reduce | 3,198,644 | -1,930,231 | -37.6% | $40.0M | 0.11% |
| 2025 Q3 | 2025-11-14 | Add | 5,128,875 | 3,585,875 | +232.4% | $46.9M | 0.12% |
| 2025 Q2 | 2025-08-14 | Reduce | 1,543,000 | -1,684,792 | -52.2% | $8.4M | 0.02% |
| 2025 Q1 | 2025-05-15 | Reduce | 3,227,792 | -1,172,208 | -26.6% | $20.3M | 0.07% |
| 2024 Q4 | 2025-02-14 | Hold | 4,400,000 | — | 0.0% | $18.1M | 0.06% |
| 2024 Q3 | 2024-11-14 | Hold | 4,400,000 | — | 0.0% | $14.7M | 0.05% |
| 2024 Q2 | 2024-08-14 | Hold | 4,400,000 | — | 0.0% | $13.1M | 0.05% |
| 2024 Q1 | 2024-05-15 | Hold | 4,400,000 | — | 0.0% | $15.2M | 0.06% |
| 2023 Q4 | 2024-02-14 | Hold | 4,400,000 | — | 0.0% | $5.9M | 0.02% |
| 2023 Q3 | 2023-11-14 | Hold | 4,400,000 | — | 0.0% | $9.6M | 0.04% |
| 2023 Q2 | 2023-08-14 | Hold | 4,400,000 | — | 0.0% | $10.5M | 0.04% |
| 2023 Q1 | 2023-05-15 | Hold | 4,400,000 | — | 0.0% | $8.1M | 0.04% |
| 2022 Q4 | 2023-02-14 | Hold | 4,400,000 | — | 0.0% | $8.5M | 0.04% |
| 2022 Q3 | 2022-11-14 | New | 4,400,000 | 4,400,000 | — | $6.8M | 0.03% |
| 2022 Q2 | 2022-08-15 | — | — | — | — | — | — |
| 2021 Q3 | 2022-05-16 | — | — | — | — | — | — |
| 2021 Q4 | 2022-05-16 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-16 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-16 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-17 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-16 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-16 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-07 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-13 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-14 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-15 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-14 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.